Latest bird flu Stories
A team of Chinese researchers has discovered the first probable case of human to human transmission of H7N9 bird flu in China. While the news is startling, the researchers still stress that it does not spread efficiently in this manner.
A newly released paper is suggesting that an antiviral drug used to treat bird flu patients may not be as effective as health officials had hoped, leaving the door open for further illness and possible death.
The new bird flu strain that has so far killed 11 people in China has been showing signs that it is quickly adapting to mammalian (particularly human) hosts.
On June 21, the second of two bird flu studies was released. It put fears to rest regarding terrorism and the global epidemic. Specifically, five genetic mutations were mentioned in the report.
It was assumed that H5N1 bird flu is a rare disease that kills roughly 59 percent of the people it infects, but a new US study published in the journal Science suggests it may be more common and less deadly than previously believed.
In the current issue of Science, researchers at Michigan State University demonstrate how a new virus evolves, which sheds light on how easy it can be for diseases to gain dangerous mutations.
Chickens genetically modified to prevent them spreading bird flu have been produced by researchers at the Universities of Cambridge and Edinburgh.
Almost 90 per cent of the world's population will not have timely access to affordable supplies of vaccines and antiviral agents in the current influenza pandemic, but it is possible that inexpensive generic drugs that are readily available, even in developing countries, could save millions of lives.
SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) confirmed today that the Aethlon Hemopurifier(R) is a candidate to treat the H1N1 Swine flu virus.
- In medieval musical notation, a sign or neume denoting a shake or trill.